Currently out of the existing stock ratings of Max Masucci, 17 are a HOLD (18.89%), 73 are a BUY (81.11%).

Max Masucci

Work Performance Price Targets & Ratings Chart

Analyst Max Masucci, carries an average stock price target met ratio of 46.72% that have a potential upside of 33.04% achieved within 149 days. Previously, Max Masucci worked at COWEN.

Max Masucci’s has documented 171 price targets and ratings displayed on 23 stocks. The coverage was on Healthcare, Energy sectors.

Most recent stock forecast was given on BLFS, BioLife Solutions at 13-Nov-2024.

Wall Street Analyst Max Masucci

Analyst best performing recommendations are on BDSX (BIODESIX ).
The best stock recommendation documented was for QTRX (QUANTERIX CORP) at 10/6/2020. The price target of $40 was fulfilled within 1 day with a profit of $3.1 (8.4%) receiving and performance score of 84.01.

Average potential price target upside

of $128 (33.52%) on BDSX (BIODESIX ).
of $81.01 (16.5%) on ILMN (ILLUMINA).
of $41.6 (83.09%) on NTRA (NATERA).

BDSX Biodesix GNMK GenMark Diagnostics ILMN Illumina NTRA Natera BLFS BioLife Solutions DMTK DermTech QTRX Quanterix Corp ISO IsoPlexis Corp MXCT MaxCyte NAUT Nautilus Biotechnology SMFR Sema4 Holdings Corp TKNO Alpha Teknova XGN Exagen GH Guardant Health HOLX Hologic PKI PerkinElmer EVO Evotec SE ADR BRKR Bruker CDXS Codexis CTKB Cytek Biosciences GTH Genetron Holdings Ltd CEMI Chembio Diagnostics SM SM Energy Co

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kyle Mikson (CANACCORD)